Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOBRAMYCIN for Cystic fibrosis lung: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 212 adverse event reports in the FDA FAERS database where TOBRAMYCIN was used for Cystic fibrosis lung.

Most Reported Side Effects for TOBRAMYCIN

Side Effect Reports % Deaths Hosp.
Off label use 1,467 12.7% 158 489
Death 888 7.7% 880 50
Cough 738 6.4% 18 260
Dyspnoea 706 6.1% 22 367
Pneumonia 700 6.0% 43 578
Hospitalisation 688 5.9% 5 601
Condition aggravated 669 5.8% 43 439
Cystic fibrosis 646 5.6% 49 520
Infective pulmonary exacerbation of cystic fibrosis 504 4.4% 16 435
Drug ineffective 453 3.9% 104 174
Acute kidney injury 372 3.2% 32 230
Malaise 361 3.1% 12 165
Ill-defined disorder 344 3.0% 4 315
Product use issue 338 2.9% 52 77
Infection 289 2.5% 16 200

Other Indications for TOBRAMYCIN

Cystic fibrosis (4,219) Product used for unknown indication (2,332) Pseudomonas infection (984) Bronchiectasis (977) Off label use (386) Lung disorder (280) Pneumonia pseudomonal (170) Chronic obstructive pulmonary disease (151) Infective pulmonary exacerbation of cystic fibrosis (144) Pneumonia (135)

Other Drugs Used for Cystic fibrosis lung

AZTREONAM LYSINE (1,883) DORNASE ALFA (79) AZTREONAM (20) PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (20) ELEXACAFTOR\IVACAFTOR\TEZACAFTOR (12) PIPERACILLIN\TAZOBACTAM (11) DUPILUMAB (10) TOBI PODHALER (10) COLISTIN (9) MEROPENEM (9)

Related Pages

TOBRAMYCIN Full Profile All Cystic fibrosis lung Drugs TOBRAMYCIN Demographics TOBRAMYCIN Timeline